SBIR/STTR Research Award

Communication in Infants and Social Screener : The CISS

Award identifier 65cf0eea117b79817893db128c7df0fe2aa876f092cf62bd44ae8fd49b4d9513Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$143,056

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
QM4D, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PA12-088
Topic code
NIGMS

Research abstract

DESCRIPTION: Molecular simulations have been widely applied to determine the structures and thermodynamic properties of organic compounds, the conformational characteristics and reactivity of proteins and nucleic acids, and the ligand-protein bindings. Still, the scope of the applications has been limited by the balance between accuracy and computational speed. In particular, the popular quantum-mechanical/molecular mechanical (QM/MM) approach has been largely limited to the single-configuration calculations due to the fact that QM computation is slow to be subject to dynamic sampling needed for the evaluation of free energy. In this SBIR application, we propose a software development based on a technology that will drastically shift this balance in QM/MM computation. Our new technology, called QM/MM-MFEP (minimum free energy path), will speeds up the combined QM/MM dynamic simulations hundreds of times. It achieves the efficiency gain by computing the dynamics of the MM subsystem separately from the QM subsystem such that the QM problem is solved with the averaged effect of the MM environment based on rigorous theory. In the Phase I of this project, we plan to make robust and efficient implementation of QM/MM-MFEP for solvation that will calculate accuratelyand efficiently the free-energy profiles of chemical reactions and relative free energies of ligands in solution, both of which are essential in the modeling of chemical and biological applications and practical applications in drug discovery. We will also improve the computation of the QM and MM electrostatic potential. In Phase II we will aim to enable free energy calculations of enzymatic reactions and ligand-protein binding affinities, and pKa's of ligands. The end product will be a QM/MM package thatcombines the best of the QM and MM, i.e. the QM accuracy and MM statistical simulation of the condensed phase, and afford its users routine simulations of reactions, binding affinities and solvation effects in condensed phases with high accuracy and significantly expand the reach of molecular modeling. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: We will develop a new molecular modeling technology that will dramatically improve the efficiency of the modeling. Molecular modeling is essential to the biological research and development and in drug discovery. The new technology will greatly enhance the quality and the productivity of the scientists in the practice of molecular modeling.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.